scholarly journals Recrescimento Tumoral de Adenocarcinoma após Estratégia “Watch and Wait“ no Contexto da Pandemia Covid-19

2021 ◽  
Author(s):  
R. Prá Buss ◽  
A. L. Pincinato ◽  
B. C. Passos Santana ◽  
M. Pinto Ribeiro ◽  
L. De Oliveira Ribeiro ◽  
...  
Keyword(s):  
2020 ◽  
Vol 22 (Supplement_2) ◽  
pp. ii46-ii46
Author(s):  
Jonathan Weller ◽  
Sophie Katzendobler ◽  
Philipp Karschnia ◽  
Stefanie Lietke ◽  
Rupert Egensperger ◽  
...  

Abstract BACKGROUND Current treatment guidelines for oligodendrogliomas (OD) recommend watch-and-wait strategies after gross total resection and radiation with subsequent chemotherapy (procarbazine, CCNU and vincristine (PCV)) after incomplete resection. The value of chemotherapy alone as an option to delay the risk of late cognitive deficits is not well defined yet. Here, we retrospectively investigated long-term outcome in OD WHO II with respect to initial therapy and tumor volume in magnetic resonance imaging (MRI). METHODS A total of 142 patients with OD WHO (World Health Organization) II according to WHO 2016 were retrospectively included. Patients either had watch and wait (W&W) after histological sampling through stereotactic biopsy (n=59) or tumor resection (n=27) or else stereotactic biopsy with subsequent temozolomide (TMZ) (n=26) or PCV (n=30). Pre- and post-therapeutic T2 tumor volumes were obtained. Progression-free survival (PFS), post-recurrence PFS (PR-PFS) and rate of secondary malignization after 10 years (MR-10yrs) were correlated with clinical and volumetric data. RESULTS PFS was significantly longer in the PCV cohort compared to TMZ (9.1 vs. 3.6 years, p = 0.04), even after matching patients according to age and initial tumor volume (9.1 vs 4.7 yrs, p = 0.03). PFS in the W&W cohort was 5.1 years and 4.4 years in those receiving tumor resection only. MR-10yrs was 4% in PCV cohort, 18% in the W&W cohort and 52% in the resection only cohort (p = 0.01). In the W&W cohort, patients treated with PCV at first relapse had a longer PR-PFS than those treated with TMZ (in years, 7.2 vs 4.0, p = 0.04). Multivariate analysis confirmed initial PCV therapy (p = 0.01) and initial T2 tumor volume (p = 0.02) to be prognostic. CONCLUSION In oligodendrogliomas WHO II PCV chemotherapy alone is superior in terms of PFS and rate of secondary malignization compared to TMZ chemotherapy alone or tumor resection only.


2020 ◽  
Vol 146 (10) ◽  
pp. 2631-2638
Author(s):  
João Cortez Pinto ◽  
António Dias Pereira ◽  
Ana Pimenta ◽  
Cátia Pedro ◽  
Gonçalo Fernandez ◽  
...  

Cancers ◽  
2021 ◽  
Vol 13 (9) ◽  
pp. 2267
Author(s):  
Rumana N. Hussain ◽  
Sarah E. Coupland ◽  
Helen Kalirai ◽  
Azzam F. G. Taktak ◽  
Antonio Eleuteri ◽  
...  

Our aim was to determine whether size impacts on the difference in metastatic mortality of genetically high-risk (monosomy 3) uveal melanomas (UM). We undertook a retrospective analysis of data from a patient cohort with genetically characterized UM. All patients treated for UM in the Liverpool Ocular Oncology Centre between 2007 and 2014, who had a prognostic genetic tumor analysis. Patients were subdivided into those with small (≤2.5 mm thickness) and large (>2.5 mm thickness) tumors. Survival analyses were performed using Gray rank statistics to calculate absolute probabilities of dying as a result of metastatic UM. The 5-year absolute risk of metastatic mortality of those with small monosomy 3 UM was significantly lower (23%) compared to the larger tumor group (50%) (p = 0.003). Small disomy 3 UM also had a lower absolute risk of metastatic mortality (0.8%) than large disomy 3 UM (6.4%) (p = 0.007). Hazard rates showed similar differences even with lead time bias correction estimates. We therefore conclude that earlier treatment of all small UM, particularly monosomy 3 UM, reduces the risk of metastatic disease and death. Our results would support molecular studies of even small UM, rather than ‘watch-and-wait strategies’.


2021 ◽  
Vol 145 ◽  
pp. 155-157
Author(s):  
Khalil Saleh ◽  
Christophe Bellanger ◽  
Gabriel Garcia ◽  
Marion Classe ◽  
Caroline Even

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Gregory Jones ◽  
Jeremias Georgiadis ◽  
Valerie Staples

Sign in / Sign up

Export Citation Format

Share Document